| Dilated cardiomyopathy |
1.87 |
6.21e-2 |
86/96 (89.58%) |
GNAS;PRKACB;TGFB1;...
|
| Fructose and mannose metabolism |
1.81 |
8.07e-2 |
30/33 (90.91%) |
AKR1B10;AKR1B1;PFKL;...
|
| Vibrio cholerae infection |
1.78 |
6.62e-2 |
44/50 (88%) |
GNAS;PRKACB;PLCG2;...
|
| Galactose metabolism |
1.73 |
1.02e-1 |
26/31 (83.87%) |
AKR1B10;AKR1B1;PFKL;...
|
| Fatty acid elongation |
1.72 |
8.45e-2 |
19/27 (70.37%) |
HACD1;HADHB;TECR;...
|
| Glycerolipid metabolism |
1.71 |
8.07e-2 |
44/61 (72.13%) |
AKR1B10;AKR1B1;LIPG;...
|
| Pentose and glucuronate interconversions |
1.70 |
7.81e-2 |
17/34 (50%) |
AKR1B10;AKR1B1;SORD;...
|
| Hypertrophic cardiomyopathy |
1.68 |
8.07e-2 |
81/90 (90%) |
TGFB1;TTN;ITGA6;...
|
| Citrate cycle (TCA cycle) |
1.67 |
8.28e-2 |
30/30 (100%) |
DLD;ACO1;SUCLG1;...
|
| MicroRNAs in cancer |
1.63 |
1.14e-1 |
146/310 (47.1%) |
CD44;FGFR3;GLS;...
|
| Glutathione metabolism |
1.61 |
1.32e-1 |
43/57 (75.44%) |
GPX2;GCLC;G6PD;...
|
| DNA replication |
1.58 |
1.61e-1 |
34/36 (94.44%) |
RFC5;MCM6;MCM5;...
|
| Phospholipase D signaling pathway |
1.56 |
1.69e-1 |
134/148 (90.54%) |
GNAS;F2R;PDGFRA;...
|
| Central carbon metabolism in cancer |
1.54 |
1.85e-1 |
67/70 (95.71%) |
FGFR3;GLS;PFKL;...
|
| Carbohydrate digestion and absorption |
1.52 |
2.21e-1 |
37/47 (78.72%) |
SLC37A4;AKT3;PIK3R1;...
|
| Choline metabolism in cancer |
1.51 |
2.25e-1 |
84/98 (85.71%) |
PDGFRA;PDGFC;AKT3;...
|
| Acute myeloid leukemia |
1.51 |
2.21e-1 |
66/67 (98.51%) |
RUNX1;LEF1;AKT3;...
|
| Regulation of actin cytoskeleton |
1.47 |
2.70e-1 |
185/218 (84.86%) |
FGFR3;F2R;GSN;...
|
| Proximal tubule bicarbonate reclamation |
1.44 |
3.20e-1 |
21/23 (91.3%) |
GLS;GLUD2;GLUD1;...
|
| Asthma |
1.44 |
3.25e-1 |
25/31 (80.65%) |
CD40;HLA-DQA1;CCL11;...
|
| Adrenergic signaling in cardiomyocytes |
1.43 |
3.25e-1 |
130/150 (86.67%) |
GNAS;PRKACB;ATP2A2;...
|
| Pancreatic secretion |
1.42 |
3.23e-1 |
87/102 (85.29%) |
GNAS;PRSS1;ATP2A2;...
|
| Arginine and proline metabolism |
1.42 |
3.26e-1 |
39/50 (78%) |
CKM;GOT1;ARG2;...
|
| Lysosome |
1.42 |
3.19e-1 |
115/128 (89.84%) |
SORT1;LAPTM4B;NPC2;...
|
| Renin secretion |
1.41 |
3.09e-1 |
61/69 (88.41%) |
GNAS;PTGER4;GUCY1A1;...
|
| Collecting duct acid secretion |
1.39 |
3.56e-1 |
22/27 (81.48%) |
ATP6V1D;CA2;ATP6V1G1;...
|
| Gap junction |
1.38 |
3.58e-1 |
72/88 (81.82%) |
GNAS;GUCY1A1;PRKACB;...
|
| Pantothenate and CoA biosynthesis |
1.38 |
3.60e-1 |
14/21 (66.67%) |
DPYD;AASDHPPT;ALDH1B1
|
| Platelet activation |
1.38 |
3.54e-1 |
106/124 (85.48%) |
GNAS;GUCY1A1;F2R;...
|
| Mucin type O-glycan biosynthesis |
1.36 |
3.58e-1 |
20/36 (55.56%) |
GALNT3;GALNT12;ST6GALNAC2;...
|
| Non-alcoholic fatty liver disease |
-1.20 |
5.44e-1 |
126/155 (81.29%) |
ADIPOQ;ADIPOR1;NR1H3;...
|
| NF-kappa B signaling pathway |
-1.21 |
5.44e-1 |
90/104 (86.54%) |
TNFSF11;SYK;TICAM1;...
|
| Protein export |
-1.22 |
5.40e-1 |
17/23 (73.91%) |
SEC61G;SEC62;SRP9;...
|
| Sulfur metabolism |
-1.23 |
5.24e-1 |
9/10 (90%) |
SELENBP1
|
| Viral myocarditis |
-1.24 |
5.26e-1 |
53/60 (88.33%) |
ICAM1;HLA-F;SGCB;...
|
| Aminoacyl-tRNA biosynthesis |
-1.24 |
5.44e-1 |
15/66 (22.73%) |
TARS2;GATC;HARS2;...
|
| Bladder cancer |
-1.25 |
5.18e-1 |
40/41 (97.56%) |
MMP9;E2F3;EGFR;...
|
| African trypanosomiasis |
-1.25 |
5.29e-1 |
32/37 (86.49%) |
HPR;ICAM1;VCAM1;...
|
| Salmonella infection |
-1.26 |
5.29e-1 |
198/249 (79.52%) |
MAPK14;MYO6;ACTR3B;...
|
| Spliceosome |
-1.30 |
4.30e-1 |
101/150 (67.33%) |
HNRNPM;SNRPC;BCAS2;...
|
| Primary bile acid biosynthesis |
-1.32 |
4.07e-1 |
15/17 (88.24%) |
AKR1D1;SLC27A5;CYP7A1;...
|
| Lipid and atherosclerosis |
-1.33 |
3.76e-1 |
190/215 (88.37%) |
MAP2K3;IKBKG;AGER;...
|
| Epithelial cell signaling in Helicobacter pylori infect... |
-1.34 |
3.67e-1 |
62/70 (88.57%) |
ADAM17;IKBKG;ATP6V0C;...
|
| Kaposi sarcoma-associated herpesvirus infection |
-1.35 |
3.75e-1 |
172/193 (89.12%) |
ATG14;SYK;TICAM1;...
|
| Rheumatoid arthritis |
-1.35 |
3.92e-1 |
78/93 (83.87%) |
ATP6V0C;IL23A;ATP6V1B1;...
|
| Breast cancer |
-1.36 |
3.76e-1 |
119/147 (80.95%) |
FZD10;RPS6KB2;FGF5;...
|
| Phototransduction |
-1.38 |
3.63e-1 |
21/29 (72.41%) |
GRK1;PDE6A;RHO;...
|
| TNF signaling pathway |
-1.38 |
3.89e-1 |
103/112 (91.96%) |
MMP9;MAPK14;CREB3L1;...
|
| Viral protein interaction with cytokine and cytokine re... |
-1.40 |
3.55e-1 |
84/100 (84%) |
CCL4;IL10RB;CX3CL1;...
|
| Cellular senescence |
-1.43 |
3.11e-1 |
139/156 (89.1%) |
E2F3;MAPK14;GADD45G;...
|
| Malaria |
-1.44 |
3.23e-1 |
44/50 (88%) |
THBS4;VCAM1;IL6;...
|
| alpha-Linolenic acid metabolism |
-1.49 |
2.51e-1 |
17/25 (68%) |
PLA2G4C;FADS2;PLA2G10;...
|
| Terpenoid backbone biosynthesis |
-1.53 |
2.10e-1 |
18/22 (81.82%) |
PDSS2;ICMT;PCYOX1;...
|
| IL-17 signaling pathway |
-1.53 |
2.20e-1 |
84/94 (89.36%) |
MMP9;MUC5B;MAPK14;...
|
| Antigen processing and presentation |
-1.67 |
6.90e-2 |
60/78 (76.92%) |
TAP2;PSME2;RFXANK;...
|
| Pertussis |
-1.71 |
5.85e-2 |
64/76 (84.21%) |
GNAI3;RELA;MAPK10;...
|
| Thiamine metabolism |
-1.71 |
7.32e-2 |
12/15 (80%) |
ALPI;ALPP;TPK1;...
|
| PPAR signaling pathway |
-1.72 |
8.57e-2 |
66/74 (89.19%) |
PDPK1;ACSBG1;SLC27A5;...
|
| Mineral absorption |
-1.78 |
8.21e-2 |
48/60 (80%) |
ATP7B;ATP1A1;FTH1;...
|
| Legionellosis |
-1.78 |
1.64e-1 |
51/57 (89.47%) |
HSF1;SAR1A;CASP3;...
|
